TrialJAMA oncology2026

Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial.

George Q Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.